aul Moss is Professor of Haematology within the Institute of Immunology and Immunotherapy at the University of Birmingham and Deputy Head of the College of Medical and Dental Sciences. He is an international figure in translational human immunology and an NIHR Senior Investigator. He was previously Chair of the Infection and Immunity Board at the Medical Research Council and also served as Chair of the Clinical and Translational Research Committee at Cancer Research UK.
Professor Moss led the UK Coronavirus Immunology Consortium (UK-CIC) that brought together leading immunologists from 20 UK universities to understand the immune response to SARS-CoV-2. UK-CIC launched in August 2020 with £6.5 million funding from UKRI and NIHR. It aimed to determine the mechanisms of virus-specific immunity and how these relate to clinical outcome in different patient groups. Published research support by UK-CIC can be viewed online.
He is currently leading the immunity strand of the COVID-19 National Core Studies Programme, initiated by Sir Patrick Vallance in October 2020, that supports research to improve our understanding of immunity against COVID-19.
As well as publishing in leading journals, including Nature, Blood and the European Journal of Immunology, Professor Moss's research has featured in the Financial Times, BBC News and The Economist.
Subject groups
-
Molecules of Life
Molecular immunology, Molecular microbiology
-
Cell Biology
Cellular and humoral immunology
